Chronic knee pain from osteoarthritis affects millions of aging adults, often leaving them with limited mobility and diminished quality of life despite conventional treatments. This comprehensive analysis reveals that non-invasive electrical stimulation technologies offer measurable relief when standard therapies fall short, potentially transforming how we approach arthritis management in older populations.
Analyzing 15 randomized controlled trials encompassing 1,137 participants, researchers evaluated five distinct electrical stimulation approaches: transcranial direct current stimulation (tDCS), neuromuscular electrical stimulation (NMES and whole-body EMS), transcutaneous electrical nerve stimulation (TENS), cranial electrical stimulation, and transcutaneous vagus nerve stimulation. The pooled data demonstrated significant improvements in both pain reduction and functional capacity, though results varied considerably between different stimulation methods.
Transcranial direct current stimulation emerged as the most consistently effective approach, delivering moderate but reliable pain relief through targeted brain stimulation. Neuromuscular electrical stimulation proved particularly valuable for individuals with muscle weakness, enhancing quadriceps strength and overall mobility alongside patient-reported improvements. TENS devices showed the most variable outcomes, suggesting this widely available technology may benefit from more refined application protocols.
This meta-analysis represents the most comprehensive evaluation of electrical stimulation for knee osteoarthritis to date, yet several limitations warrant consideration. The high heterogeneity between studies indicates substantial variability in treatment protocols, patient populations, and outcome measures. Most trials were relatively short-term, leaving questions about long-term efficacy and optimal treatment duration unanswered. While these findings support electrical stimulation as a promising adjunctive therapy, the field needs standardized protocols and larger, longer-duration studies to establish definitive clinical guidelines for this growing therapeutic approach.